Cite
HARVARD Citation
Khunti, K. et al. (2021). Associations between second‐line glucose‐lowering combination therapies with metformin and HbA1c, body weight, quality of life, hypoglycaemic events and glucose‐lowering treatment intensification: The DISCOVER study. Diabetes, obesity & metabolism. 23 (8), pp. 1823-1833. [Online].